Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Physostigmine salicylate [USP:JAN]
RN: 57-64-7
UNII: 2046ZRO9VU
InChIKey: HZOTZTANVBDFOF-PBCQUBLHSA-N

Note

  • A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.

Molecular Formula

  • C15-H21-N3-O2.C7-H6-O3

Molecular Weight

  • 413.4713
 

Classification Codes

Classification Codes

  • Cholinergic (Ophthalmic)
  • Drug / Therapeutic Agent
  • Human Data
  • Reproductive Effect

Superlist Classification Code

  • Threshold Planning Quantity (TPQ) = 100/10000 lb
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Physostigmine salicylate
  • Physostigmine salicylate [USP:JAN]

Synonyms

  • Antilirium
  • AR-44
  • CCRIS 3405
  • EINECS 200-343-8
  • Eserine salicylate
  • Isopto Eserine
  • NSC 757275
  • Physostigmine monosalicylate
  • Physostigmine salicylate
  • Physostol salicylate
  • Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate)
  • Salicylic acid, compd. with physostigmine (1:1)
  • TL-1380
  • UNII-2046ZRO9VU

Systematic Names

  • Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl methylcarbamate (1:1)
  • Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl N-methylcarbamate (1:1)
  • Physostigmine salicylate
  • Physostigmine, salicylate (1:1)
  • Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate)

Superlist Names

  • Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl methylcarbamate ester (1:1)
  • Physostigmine salicylate
  • Physostigmine, salicylate (1:1)
  • RCRA waste no. P188

Mixture Name

  • Isopto P-ES

Registry Numbers

CAS Registry Number

  • 57-64-7

FDA UNII

  • 2046ZRO9VU

Other Registry Numbers

  • 11033-04-8
  • 11036-66-1

System Generated Number

  • 0000057647

Molecular Formulas

Molecular Formula

  • C15-H21-N3-O2.C7-H6-O3

Molecular Formula Fragments

  • C15-H21-N3-O2
  • C7-H6-O3
  • COMPONENT

Structure Descriptors

InChI

InChI=1S/C15H21N3O2.C7H6O3/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2;8-6-4-2-1-3-5(6)7(9)10/h5-6,9,13H,7-8H2,1-4H3,(H,16,19);1-4,8H,(H,9,10)/t13-,15+;/m1./s1

InChIKey

HZOTZTANVBDFOF-PBCQUBLHSA-N

Smiles

CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1.OC(=O)c4ccccc4O

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LDLo subcutaneous 800ug/kg (0.8mg/kg) BEHAVIORAL: COMA

AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION		 National Technical Information Service. Vol. PB158-508,
dog LDLo subcutaneous 1200ug/kg (1.2mg/kg) BEHAVIORAL: COMA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION

AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC		 National Technical Information Service. Vol. PB158-508,
man TDLo intravenous 14ug/kg (0.014mg/kg) CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)

GASTROINTESTINAL: NAUSEA OR VOMITING		 Journal of Clinical Psychiatry. Vol. 46, Pg. 446, 1985.
mouse LD50 intraperitoneal 640ug/kg (0.64mg/kg)   Toxicology and Applied Pharmacology. Vol. 28, Pg. 227, 1974.
mouse LD50 intravenous 310ug/kg (0.31mg/kg)   Toxicology and Applied Pharmacology. Vol. 20, Pg. 474, 1971.
mouse LD50 oral 2500ug/kg (2.5mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Archives Internationales de Pharmacodynamie et de Therapie. Vol. 81, Pg. 276, 1950.
mouse LD50 subcutaneous 800ug/kg (0.8mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR

LUNGS, THORAX, OR RESPIRATION: CYANOSIS		 Journal of Pharmacy and Pharmacology. Vol. 34, Pg. 603, 1982.
rabbit LD50 intramuscular 1570ug/kg (1.57mg/kg) BEHAVIORAL: TREMOR Archives Internationales de Pharmacodynamie et de Therapie. Vol. 81, Pg. 276, 1950.
rabbit LD50 intravenous 910ug/kg (0.91mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES Toxicology and Applied Pharmacology. Vol. 165, Pg. 27, 2000.
rabbit LDLo subcutaneous 2mg/kg (2mg/kg)   Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 53, Pg. 313, 1905.
rat LD50 intramuscular 1280ug/kg (1.28mg/kg)   Drug and Chemical Toxicology. Vol. 7, Pg. 507, 1984.
rat LD50 subcutaneous 2mg/kg (2mg/kg)   Toxicology and Applied Pharmacology. Vol. 25, Pg. 569, 1973.

Physical Properties

Physical Property Value Units Temp (deg C) Source
Melting Point 150.1 deg C   EXP
log P (octanol-water) 2.380 (none)   EST
Water Solubility 1.38E+04 mg/L 25 EXP
Vapor Pressure 3.10E-16 mm Hg 25 EST
Henry's Law Constant 3.36E-22 atm-m3/mole 25 EST
Atmospheric OH Rate Constant 2.58E-10 cm3/molecule-sec 25 EST

Physical property data is provided to ChemIDplus by SRC, Inc.